ICM
AVTA

Invenomic Capital Management’s Avantax, Inc. Common Stock AVTA Stock Holding History

Invenomic Capital Management’s Portfolio AVTA Stock Details AVTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-54,807
Closed -$872K – 167
2020
Q4 		$872K Sell
54,807
-10,689
-16% -$130K 0.22% 77
2020
Q3 		$617K Sell
65,496
-26,165
-29% -$289K 0.34% 83
2020
Q2 		$1.05M Buy
91,661
+43,581
+91% +$547K 0.78% 47
2020
Q1 		$579K Buy
+48,080
New +$927K 0.47% 65

Other funds holding AVTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PCP
P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Invenomic Capital Management's AVTA Position: Q1 2021 in Review

Invenomic Capital Management sold out of Avantax, Inc. Common Stock (AVTA) in Q1 2021, closing a stake of 54,807 shares — an estimated $872K sold.

Invenomic Capital Management first reported a position in AVTA in Q1 2020 and held it in 4 quarters. The position peaked at $1.05M in Q2 2020. 143 funds tracked by Wall St. Rank hold AVTA as of Q1 2021.

  • Invenomic Capital Management reported no remaining Avantax, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Invenomic Capital Management sold 54,807 Avantax, Inc. Common Stock shares in Q1 2021, an estimated $872K.
  • Invenomic Capital Management first reported a position in Avantax, Inc. Common Stock in Q1 2020 and held it in 4 quarters.
  • Invenomic Capital Management's Avantax, Inc. Common Stock position peaked at $1.05M in Q2 2020.
  • 143 funds tracked by Wall St. Rank held Avantax, Inc. Common Stock as of Q1 2021.

Based on Invenomic Capital Management's 13F filing for Q1 2021, filed 13 May 2021.